Abstract
Surfactant dysfunction has been demonstrated in clinical and experimental studies of acute lung injury (ALI) and acute respiratory distress syndrome (ARDS). Inflammatory mediators, alveolar exudation, capillary endotheliopathy, and various other mechanisms have been indicted as the cause of surfactant dysfunction. In addition, loss of biophysical activity and damage to the type II alveolar cells leads to altered surfactant production, secretion, and recycling. These factors provide the conceptual rationale for administering exogenous surfactant in ALI/ARDS. Studies of surfactant replacement therapy in ALI/ARDS in children have shown improvement in various parameters of pulmonary function. Multiple simultaneous interventions in the treatment of ALI/ARDS have improved survival and outcomes. The objective of this review is to address the current literature and evidence supporting the administration of exogenous surfactant in the treatment of children with ARDS/ALI.
Keywords: ALI, ARDS, pediatric, surfactant replacement
Current Respiratory Medicine Reviews
Title: Surfactant Replacement Therapy in Pediatric Acute Lung Injury/Acute Respiratory Distress Syndrome
Volume: 5 Issue: 3
Author(s): Rahul Bhatia, Timothy J. Cox and James H. Hertzog
Affiliation:
Keywords: ALI, ARDS, pediatric, surfactant replacement
Abstract: Surfactant dysfunction has been demonstrated in clinical and experimental studies of acute lung injury (ALI) and acute respiratory distress syndrome (ARDS). Inflammatory mediators, alveolar exudation, capillary endotheliopathy, and various other mechanisms have been indicted as the cause of surfactant dysfunction. In addition, loss of biophysical activity and damage to the type II alveolar cells leads to altered surfactant production, secretion, and recycling. These factors provide the conceptual rationale for administering exogenous surfactant in ALI/ARDS. Studies of surfactant replacement therapy in ALI/ARDS in children have shown improvement in various parameters of pulmonary function. Multiple simultaneous interventions in the treatment of ALI/ARDS have improved survival and outcomes. The objective of this review is to address the current literature and evidence supporting the administration of exogenous surfactant in the treatment of children with ARDS/ALI.
Export Options
About this article
Cite this article as:
Bhatia Rahul, Cox J. Timothy and Hertzog H. James, Surfactant Replacement Therapy in Pediatric Acute Lung Injury/Acute Respiratory Distress Syndrome, Current Respiratory Medicine Reviews 2009; 5 (3) . https://dx.doi.org/10.2174/157339809788922324
DOI https://dx.doi.org/10.2174/157339809788922324 |
Print ISSN 1573-398X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6387 |
Call for Papers in Thematic Issues
Exposure to PM2.5 components is associated with respiratory diseases
Through continuous research on the relationship between risk factors and health, it has been found that air pollution, especially atmospheric particulate matter pollution, has become one of the main sources of global disease burden. From 1990 to 2022, the concentration of atmospheric particulate matter pollution has increased by more than ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Similarities and Differences Between Renal Sympathetic Denervation and Carotid Baroreceptor Stimulation
Current Vascular Pharmacology Industrial Chemicals and Acute Lung injury with a Focus on Exposure Scenarios
Current Respiratory Medicine Reviews Studies on Novel Pyridine and 2-pyridone Derivatives of N-arylpiperazine as α-adrenoceptor Ligands
Medicinal Chemistry Inhibition of Histone Deacetylases: A Pharmacological Approach to the Treatment of Non-Cancer Disorders
Current Topics in Medicinal Chemistry Parkinson’s Disease: Recent Updates in the Identification of Human Dopa Decarboxylase Inhibitors
Current Drug Metabolism Chemical and Potential Biological Perspectives of Genus Sarcococca (Buxaceae)
The Natural Products Journal Pathophysiology and Treatment of Obesity Hypertension
Current Pharmaceutical Design CD44 and its Role in Inflammation and Inflammatory Diseases
Inflammation & Allergy - Drug Targets (Discontinued) Gender Differences in Hemodynamic Regulation and Cardiovascular Adaptations to Dynamic Exercise
Current Cardiology Reviews Hibiscus Sabdariffa Linnaeus (Malvaceae), Curcumin and Resveratrol as Alternative Medicinal Agents Against Metabolic Syndrome
Cardiovascular & Hematological Agents in Medicinal Chemistry Preoperative Levosimendan. A New Way for Organoprotection
Current Pharmaceutical Design The Role of Transforming Growth Factor β1 in the Regulation of Blood Pressure
Current Hypertension Reviews Development and Validation of a UPLC-MS/MS Method for the Simultaneous Determination of Verapamil and Trandolapril in Rat Plasma: Application to a Pharmacokinetic Study
Current Pharmaceutical Analysis Vascular and Cellular Calcium in Normal and Hypertensive Pregnancy
Current Clinical Pharmacology Therapeutic Drugs that Slow the Heart Rate of Early Rat Embryos. Is there a Risk for the Human?
Current Pharmaceutical Design Recent Advances in Protein and Peptide Drug Delivery: A Special Emphasis on Polymeric Nanoparticles
Protein & Peptide Letters Editorial [Hot Topic: Cardiovascular Risk and Inflammation: Pathophysiological Mechanisms, Drug Design, and Targets Executive (Guest Editor: Armen Yuri Gasparyan)]
Current Pharmaceutical Design Obstetrical Hemorrhage Review
Current Women`s Health Reviews Usefulness of Home Blood Pressure in the Diagnosis and Control of Hypertension in Primary Care
Current Hypertension Reviews Silent Cerebral Damage in Hypertension
Current Hypertension Reviews